SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center

P U B L I C A T I O N S 2 0 0 2 - 2 0 0 3
Georgel, PT, Fletcher, TM, Hager, GL, and
Hansen, JC. Formation of higher-order secondary
and tertiary chromatin structures by genomic
mouse mammary tumor virus promoters. Genes
& Development 17:1617-29, 2003.
Fletcher, TM. Telomere higher-order structure
and genomic instability. IUBMB Life 55:443-49,
2003.
Enninga, J, Levy, DE, Blobel, G, and Fontoura,
BM. Role of nucleoporin induction in releasing
an mRNA nuclear export block. Science
295:1523-5, 2002.
Comment on the Science publication by
Enninga, J, Levy, DE, Blobel, G, and Fontoura,
BM. Nature Cell Biology 4:E55, 2002.
Yin, X, Fontoura, BM, Morimoto, T, and Carroll,
RB. Cytoplasmic complex of p53 and eEF2.
Journal of Cellular Physiology 196:474-82, 2003.
Enninga, J, Levay, A, and Fontoura, BM. Sec13
shuttles between the nucleus and the cytoplasm
and stably interacts with Nup96 at the nuclear
pore complex. Molecular and Cellular Biology
23:7271-7284, 2003.
Franzmann, EJ, Schroeder, GL, Goodwin, WJ,
Weed, DT, Fisher, P, and Lokeshwar, VB. Expression
of tumor markers hyaluronic acid and hyaluronidase
(HYAL1) in head and neck tumors.
International Journal of Cancer 106:438-45, 2003.
Green, RM, DeVries, KO, Bernstein, J,
Goodman, KW, Kaufmann, R, Kiessling, AA,
Levin, SR, Moss, SL, and Tauer, CA. Overseeing
research on therapeutic cloning: A private ethics
board responds to its critics. Hastings Center
Report 32:27-33, 2002
Markovitz, BP and Goodman, KW. Case reports on
the web redux: confidentiality still in jeopardy. Proceedings
from the AMIA Symposium 926, 2003.
Civantos, FJ, Gomez, C, Duque, C, Pedroso, F,
Goodwin, WJ, Weed, DT, Arnold, D, and
Moffat, F. Sentinel node biopsy in oral cavity
cancer: correlation with PET scan and immunohistochemistry.
Head & Neck 25:1-9, 2003.
164
Franzmann, EJ, Schroeder, GL, Goodwin, WJ,
Weed, DT, Fisher, P, and Lokeshwar, VB. Expression
of tumor markers hyaluronic acid and hyaluronidase
(HYAL1) in head and neck tumors.
International Journal of Cancer 106:438-45, 2003.
Cheng, JC, Matsen, CB, Gonzales, FA, Ye, W,
Greer, S, Marquez, VE, Jones, PA, Selker, EU.
Inhibition of DNA methylation and reactivation
of silenced genes by zebularine. Journal of the
National Cancer Institute March 5;95:399-409,
2003.
Han, Z, Wei, W, Dunaway, S, Darnowski, JW,
Calabresi, P, Sedivy, J, Hendrickson, EA, Balan,
KV, Pantazis, P, and Wyche, JH. Role of p21 in
apoptosis and senescence of human colon cancer
cells treated with camptothecin. Journal of Biological
Chemistry 277(19):17154-60, 2002.
Hu, X, Han, Z, Wyche, JH, and Hendrickson,
EA. Helix 6 of tBid is necessary but not sufficient
for mitochondrial binding activity. Apoptosis
8:277-89, 2003.
Pantazis, P, Han, Z, Balan, K, Wang, Y, and
Wyche, JH. Camptothecin and 9 nitrocamptothecin
(9NC) and anti-cancer, anti-HIV, and cell-differentiation
agents. Development of resistance,
enhancement of 9NC-induced activities, and
combination treatments in cell and animal
models. Anticancer Research 23:3623-38, 2003.
Hu, X, Balan, KV, Ramos-DeSimone, N, Wyche,
JH, Han, Z, and Pantazis, P. Differential susceptibility
to 9-nitrocamptothecin (9-NC)-induced
apoptosis in clones derived from a human ovarian
cancer cell line: possible implications in the treatment
of ovarian cancer patients with 9-NC. Anticancer
Drugs 14:427-36, 2003.
Barmak, K, Harhaj, E, and Wigdahl, B. Mediators
of central nervous system damage during the
progression of HTLV-I-associated myelopathy/
tropical spastic paraparesis. Journal of
Neurovirology 9:522-9, 2003.
UM/Sylvester Comprehensive Cancer Center Scientific Report 2004